Doaa Aref, CEO at Chefaa, told Daily NewsPK how they are connecting patients to pharmacies all over Egypt in order to make it easier for them to get their medications specially patients with chronic condition and they also offer other range of services to further assist them.
1. What led you to create ‘Chefaa’? When was it founded?
Chefaa was founded in 2017. Three Years ago, I was diagnosed with thyroid cancer, surprise!! surgery was the easy part. The problem was to get my daily lifelong medications sustainably; sometimes I couldn’t find it, sometimes I would get the wrong medicine if ordered over the phone and I would simply forget to take it!!
2. What is the core service/solution you are providing? What are the pain points that you are targeting and what is the key differentiating factor from similar offerings?
We offer 2 mobile apps connecting patients & pharmacies so patients can order, schedule and refill their recurring prescriptions as well as non-pharmaceuticals and non-prescriptions from the nearest pharmacy according to GPS location. Chronic patients can schedule to get 30-days worth of dosage once per month together with dosage reminders. Patients can get all relevant non-prescriptions and non-pharmaceuticals from Chefaa store. We offer free services as well to patients ; 24/7 support offering free pharmaceutical consultations by licensed pharmacists and we have the first Arabic speaking pharmaceutical blog to educate the public about the sound use of medicine.
All our services are designed around chronic patients. We are AI-powered, GPS-enabled platform to help chronic patients have sustained access to their recurring medicine
3. What are the parameters to measure client satisfaction?
Our customer care center returns to customers asking for feedback and suggestions to be better
4. What is your future outlook and what do you stand to achieve by next year?
We are now operational all over Egypt, we have launched our private label and white label products line and we are planning to expand beyond Egypt.
